Profile of ligand specificity of the vitamin D binding protein for 1α,25-dihydroxyvitamin d3 and its analogs

作者: June E. Bishop , Elaine D. Collins , William H. Okamura , Anthony W. Norman

DOI: 10.1002/JBMR.5650090818

关键词:

摘要: The profile of structural preference for the ligand binding domain human vitamin D protein (DBP) was determined by steroid competition assay 71 analogs 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3]. following categories modification were evaluated [values represent fold change; R = reduction, I increase in to DBP from reference alpha, 25(OH)2D3]: (1) deletion A ring alpha-hydroxyl-(20-1600I); (2) conversion triene system previtamin form (6-40R); (3) addition substituents carbon 11 C (4-14R); (4) inversion C/D junction (8-20R); (5) unsaturation (16-ene; 4-140R); (6) replacement hydrogen with deuterium atoms (no effect); alteration side chain (7) adding or deleting (5-12R); (8) fluorines (0.2-10R); (9) presence (22-ene, 0-5R; 23-ene, 3R-10I; 23-yne, 5-20R); (10) hydroxyls (2-100R); and (11) an aromatic (0-20I). Thus could tolerate only modest changes structure alpha,25(OH)2D3 without a reduction analog. increases seen triple bond at carbon-23 may be indicative preferred conformation flexible 25(OH)2D3 chain. In addition, comparison made that HL-60 cell nuclear receptor. Both domains equivalently accommodate side-chain cyclopropyl group, 22-ene lengthening two carbons, four six fluorine atoms, substitution oxygen 22, 22-[m-(dimethylhydroxymethyl)phenyl] group DPB better than receptor 22-(p-hydroxyphenyl) absence alpha-hydroxyl. contrast, modifications: 16-ene, 16-ene plus 23-yne unsaturation, beta-hydroxyl.

参考文章(33)
JY Zhou, AW Norman, M Akashi, DL Chen, MR Uskokovic, JM Aurrecoechea, WG Dauben, WH Okamura, HP Koeffler, Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism Blood. ,vol. 78, pp. 75- 82 ,(1991) , 10.1182/BLOOD.V78.1.75.75
R Bouillon, K Allewaert, J.P. van Leeuwen, B.K. Tan, D.Z. Xiang, P De Clercq, M Vandewalle, H.A. Pols, M.P. Bos, H Van Baelen, Structure function analysis of vitamin D analogs with C-ring modifications. Journal of Biological Chemistry. ,vol. 267, pp. 3044- 3051 ,(1992) , 10.1016/S0021-9258(19)50692-5
Wayne R. Wecksler, Anthony W. Norman, Structural aspects of the binding of 1 alpha, 25-dihydroxyvitamin D3 to its receptor system in chick intestine. Methods in Enzymology. ,vol. 67, pp. 494- 500 ,(1980) , 10.1016/S0076-6879(80)67061-X
Roger Bouillon, Frans A. Van Assche, Hugo Van Baelen, Walter Heyns, Pieter De Moor, Influence of the Vitamin D-binding Protein on the Serum Concentration of 1,25-Dihydroxyvitamin D3: SIGNIFICANCE OF THE FREE 1,25-DIHYDROXYVITAMIN D3 CONCENTRATION Journal of Clinical Investigation. ,vol. 67, pp. 589- 596 ,(1981) , 10.1172/JCI110072
Helmut Reichel, H. Phillip Koeffler, Anthony W. Norman, The role of the vitamin D endocrine system in health and disease. The New England Journal of Medicine. ,vol. 320, pp. 980- 991 ,(1989) , 10.1056/NEJM198904133201506
JUNKO ABE, TOSHIAKI NAKANO, YASUHO NISHII, TOSHIO MATSUMOTO, ETSURO OGATA, KYOJI IKEDA, A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology. ,vol. 129, pp. 832- 837 ,(1991) , 10.1210/ENDO-129-2-832
Junko Abe, Yumiko Takita, Toshiaki Nakano, Chisato Miyaura, Tatsuo Suda, Yasuho Nishii, A SYNTHETIC ANALOGUE OF VITAMIN D3, 22-OXA-lα,25-DIHYDROXYVITAMIN D3 IS A POTENT MODULATOR OF IN VIVO IMMUNOREGULATING ACTIVITY WITHOUT INDUCING HYPERCALCEMIA IN MICE Endocrinology. ,vol. 124, pp. 2645- 2647 ,(1989) , 10.1210/ENDO-124-5-2645